Mr. Rob Hill of Emerald Health reports

EARLY WARNING NEWS RELEASE

Emerald Health Therapeutics Inc. today acquired control and direction (via its 51-per-cent-owned affiliate, 1160305 B.C. Ltd.) of 3,030,303 common share purchase warrants of Vanc Pharmaceuticals Inc., of Suite 810, 789 West Pender St., Vancouver, B.C., V6C 1H2, pursuant to a supply and distribution agreement. Each warrant is exercisable into one common share of Vanc for a period of 24 months at an exercise price of 33 cents, subject to accelerated expiry provisions.

Immediately before the transaction, the company had direct ownership of 1,666,667 shares representing approximately 5.86 per cent of the issued and outstanding shares and 1,666,667 share purchase warrants for the purchase of an additional 1,666,667 shares. Following the transaction, the company held direct ownership of 1,666,667 shares representing approximately 5.86 per cent of the issued and outstanding shares. The company also holds directly and has control and direction over 4,696,970 share purchase warrants. Assuming the exercise of all of the warrants, the company would own directly and have control and direction over a total of 6,363,637 shares, or approximately 19.19 per cent of Vanc's then issued and outstanding share capital, assuming no other shares are issued.

Emerald acquired control and direction over the warrants for investment purposes. The company may sell its securities of Vanc either on the open market or through private dispositions in the future, depending on market conditions, reformulation of plans and/or other relevant factors.

This news release is being issued pursuant to Part 3 of National Instrument 62-103 -- The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. A copy of the report filed by Emerald in connection with the acquisition of the warrants will be available on Vanc's SEDAR profile, and can also be obtained directly from the company.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. It is adding a 500,000-square-foot greenhouse in Metro Vancouver to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald owns 50 per cent of a joint venture with Village Farms International Inc. that is converting an existing 1.1 million square ft greenhouse in Delta, B.C., to grow cannabis. Emerald's team is highly experienced in life sciences, product development and large-scale agribusiness.